- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04248881
Step up to Health, Nigeria! Impact of World Cancer Day Walk on Health Behaviors Among Nigerians
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cancer awareness is a critical element of cancer prevention and control. Creating public awareness on risk factors, preventative strategies, and the importance of early screening is the foundation upon which a cancer control program must be constructed. Ideally, efforts should include knowledge of the problem and its solutions, a group of people who respect and care for the populations they want to serve, and importantly, resources.
Nigeria is the most populous black nation in the world with a population of over 196 million, more than 500 ethnic groups, 380 languages, and a diverse range of cultural, traditional and religious beliefs. Nigeria constitutes approximately 20% of the population of Africa and slightly more than 50% of the West African population. Cancer is a critical public health problem in this population. Nigeria is a major contributor to the overall cancer burden on the continent with 72,000 cancer deaths in 2012 and 115,950 new cases of cancer and 70,327 cancer deaths in 2018. Nigerians also have one of the world's poorest 5-year cancer survival rates.
Breast cancer is the most frequently diagnosed cancer in Nigerian women and the leading cause of cancer death in Nigeria, with an estimated 26,310 new cases and 11,564 deaths in 2018 (44% death rate). Breast cancer incidence in this population historically has been low but is now increasing. By comparison, in the United States (population 329 million) there were 30,700 new breast cancer cases and 6,310 deaths in 2016. Another female cancer - cervical, is 99% preventable, however, it is the second leading cause of cancer death in Nigeria with over 26 deaths every day. By comparison, in the United States between 2013-2017, the average annual death rate of cervical cancer was 2.3% per 100,000 (age adjusted to the 2000 US standard population). Prostate cancer is the leading cause of cancer deaths in Nigerian men with 13,078 new cases (which is 29.1%) and 5,806 deaths in 2018. The age-standardized incidence rates (ASR) for prostate cancer was 32.8 new cases per 100,000 men and mortality rate was about 16.3 per 100,000 men in 2018. On a daily basis, at least 15 men die of prostate cancer in Nigeria. By comparison, in the United States prostate cancer death rates in men declined 52% from 1993 to 2017.
Strategies for prevention and early detection are imperative in the reduction of cancer death rates globally; awareness campaigns (such as the annual "World Cancer Day Walk" in Abuja) are critical to educate the general population on cancer risk factors, the benefits of screening and early detection, and to offer free cancer screening to all populations.
This study "Step up to Health, Nigeria! Impact of World Cancer Day Walk on Health Behaviors Among Nigerians" will describe the sociodemographic and risk factor distribution of the Abuja, Nigeria "World Cancer Day Walk" participants according to their motive for participation, and secondarily, to investigate the impact of the event on educating attendees from the general population about cancer prevention and screening, in particular the importance of being physically active and maintaining a healthy body weight. Obesity is a known risk factor contributing to the development of cancer and NCD's.
The study will take place in Abuja, Nigeria on Feb 1, 2020 during the 6th Annual "World Cancer Day Walk" sponsored by Project PINK BLUE, a registered Nigerian nonprofit cancer organization, viz. Health & Psychological Trust Centre (CAC/IT/NO 73960).
The purpose of the "World Cancer Day Walk" is to create awareness and advocate for better cancer care for Nigerians. The event offers free breast, cervical, and prostate cancer screenings; heath education and information about cancer risk reduction; and group physical activities that include a 5km Walk, 10km Race, 20km Ride, 5km Skate, 50km Cycle, and Marathon.
On the day of the event, the in-field research team will distribute a voluntary, one-page questionnaire to the anticipated 3,000 event participants to ascertain demographic information, cancer risk factors, motivations for attending the event, and lifestyle behaviors. Subjects will be recruited voluntarily onsite during the event following inclusion and exclusion criteria. Informed consent will be taken.
The questionnaire is 27 questions. Part one (eight questions) captures basic demographic information. Part two (six questions) captures personal and family history of cancer and cancer screening. Part three (six questions) captures information about the motivation for attending the event (free screening vs. fun/activities) and preferred ways to receive healthy lifestyle and cancer risk reduction / prevention information. Part four (five questions) captures lifestyle behaviors. Part five is the validated seven question International Physical Activity Questionnaire (IPAQ) instrument that measures physical activity and reduced sedentary behavior over the last seven days.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Abuja, Nigeria
- Project Pink Blue
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male and Female age 18 and over
- Willing and able to converse and/or read and write in either English or Pidgin English.
Exclusion Criteria:
* Participants who are unable to provide informed consent to the study due to cognitive or physical impairment, based on self-report.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Intervention Group
Participants having previously attended at least once in previous years the "World Cancer Day Walk" will be considered as the group exposed to the health education intervention (returning).
|
Healthy lifestyle information (education) is distributed to participants during the "World Cancer Day Walk" via brochure, lectures, and professional counseling.
|
No Intervention: Control Group
The control/non-exposed group will be the participants who are attending the "World Cancer Day Walk" for the first time in 2020 (first timers) and have not yet received health education information.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compare the sociodemographic and risk factor distribution of the "World Cancer Day Walk" participants who are attending the event for "free breast, cervical or prostate screening" with participants who are attending for "fun and activities".
Time Frame: Pre-intervention
|
The brief survey instrument captures participant sociodemographic characteristics.
Participants are asked to provide known risk factors for cancer and to indicate if they are attending for "free cancer screening" or "fun/activities".
|
Pre-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compare physical activity metrics between those who are attending "World Cancer Day Walk" for the first time versus participants who have attended a previous "World Cancer Day Walk".
Time Frame: Pre-intervention
|
The International Physical Activity Questionnaire (IPAQ) measures self-reported time spent per week doing vigorous and moderate activity in the last 7 days; time spent walking in the last 7 days, and time spent sitting down in the last 7 days.
It is a "fill in the blank" survey instrument.
|
Pre-intervention
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Jemal A, Brawley OW. Increasing cancer awareness and prevention in Africa. Ecancermedicalscience. 2019 Jul 25;13:939. doi: 10.3332/ecancer.2019.939. eCollection 2019.
- Jedy-Agba EE, Oga EA, Odutola M, Abdullahi YM, Popoola A, Achara P, Afolayan E, Banjo AA, Ekanem IO, Erinomo O, Ezeome E, Igbinoba F, Obiorah C, Ogunbiyi O, Omonisi A, Osime C, Ukah C, Osinubi P, Hassan R, Blattner W, Dakum P, Adebamowo CA. Developing National Cancer Registration in Developing Countries - Case Study of the Nigerian National System of Cancer Registries. Front Public Health. 2015 Jul 30;3:186. doi: 10.3389/fpubh.2015.00186. eCollection 2015.
- Brawley OW. The role of government and regulation in cancer prevention. Lancet Oncol. 2017 Aug;18(8):e483-e493. doi: 10.1016/S1470-2045(17)30374-1. Epub 2017 Jul 26.
- Rimer BK, Glassman B. Is there a use for tailored print communications in cancer risk communication? J Natl Cancer Inst Monogr. 1999;(25):140-8. doi: 10.1093/oxfordjournals.jncimonographs.a024190.
- Brawley OW, Cowal SG. Civil society's role in efforts to control women's cancers. Lancet. 2017 Feb 25;389(10071):775-776. doi: 10.1016/S0140-6736(16)31799-8. Epub 2016 Nov 1. No abstract available.
- Oyetunde MO. Perception and management of cancer among the Yoruba in Ibadan, Nigeria. Afr J Med Med Sci. 2010 Sep;39(3):181-92.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Nigeria Cancer Walk
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Prevention
-
German Cancer Research CenterUniversity of Music, Drama, and Media HannoverNot yet recruiting
-
M.D. Anderson Cancer CenterActive, not recruitingCancer PreventionUnited States
-
IWK Health CentreLaval University; Canadian Association of Fire ChiefsRecruiting
-
AshtaYoga, LLCColumbia University; University Of Nigeria Teaching Hospital; Project PINKBLUE... and other collaboratorsNot yet recruitingStep up to Health, Nigeria! Impact of 2022 World Cancer Day Walk on Health Behaviors Among NigeriansCancer PreventionNigeria
-
HealthPartners InstituteCompleted
-
Case Comprehensive Cancer CenterActive, not recruiting
-
M.D. Anderson Cancer CenterWithdrawnCancer | Prevention Harmful Effects
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedTobacco Use Cessation | Cancer PreventionUnited States
-
University of California, DavisRecruitingCancer Awareness and Prevention EducationUnited States
-
William Paterson University of New JerseyCompletedDiet Modification | Cancer Prevention | Vegetable IntakeUnited States
Clinical Trials on Healthy Lifestyle Education
-
Hakan AvanCompleted
-
China National Center for Cardiovascular DiseasesRecruitingHypertension | High-normal Blood PressureChina
-
Catholic University of the Sacred HeartUnknown
-
Maimónides Biomedical Research Institute of CórdobaCarlos III Health InstituteActive, not recruitingFood Insecurity | Healthy Lifestyle | Vulnerable Population | Cardiovascular HealthSpain
-
UnitedHealth GroupCompletedDiabetes Mellitus, Type 2 | PreDiabetesUnited States
-
The University of Hong KongSimon K.Y.Lee FoundationCompletedFrail Elderly SyndromeHong Kong
-
Chinese Academy of SciencesCalifornia Walnut CommissionCompleted
-
University of Maryland, BaltimoreNational Center for Advancing Translational Sciences (NCATS)RecruitingNeoplasms | Fatigue | Time | Therapy | Diet Therapy | Survivorship | Fasting, IntermittentUnited States
-
University of MichiganCompletedPregnancy | Postpartum Period
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Michael... and other collaboratorsActive, not recruiting